HR6509Referred to Committee

SAFE Drugs Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-12-09
Introduced
16
Cosponsors
HR
ⓘ
Type

Sponsor

Rudy Yakym III
Rudy Yakym III
Republican · IN · Representative
Votes with party: 99.1% (554 recorded votes)

Full profile: /officials/Y000067

Source: Congress.gov · FEC

Cosponsors (16)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-12-09

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

The bill would establish new safety standards and oversight procedures for pharmaceutical drugs, likely including requirements for manufacturers to report adverse effects more quickly and for the FDA to have stronger authority to monitor drug safety after approval. It would affect drug companies, patients who take medications, and healthcare providers by potentially requiring more rigorous testing and transparency about drug risks. The goal appears to be preventing unsafe drugs from reaching patients and ensuring faster removal of dangerous medications from the market.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.